Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1538-2443
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab ; volume:28 ; number:2 ; day:23 ; month:3 ; year:2022 ; pages:335-338 ; date:4.2022
Journal of neurovirology ; 28, Heft 2 (23.3.2022), 335-338, 4.2022
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13365-022-01059-2
- URN
-
urn:nbn:de:101:1-2022080623012831446267
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boesl, Fabian
- Allers, Kristina
- Herm, Juliane
- Scheider, Thomas
- Franke, Christiana
- SpringerLink (Online service)
Other Objects (12)
Progressive multifocal leukoencephalopathy in AIDS
Intravenous immunoglobulins in neurological diseases
Innovative therapeutic concepts of progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy in the absence of immunosuppression
Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors
Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression
Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy
Evolution of progressive multifocal leukoencephalopathy in HIV-infected patients
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
Smoldering myeloma presenting as progressive multifocal leukoencephalopathy: a case report
Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy in AIDS
Intravenous immunoglobulins in neurological diseases
Innovative therapeutic concepts of progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy in the absence of immunosuppression
Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors
Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression
Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy
Evolution of progressive multifocal leukoencephalopathy in HIV-infected patients
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
Smoldering myeloma presenting as progressive multifocal leukoencephalopathy: a case report
Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy in AIDS
Intravenous immunoglobulins in neurological diseases
Innovative therapeutic concepts of progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy in the absence of immunosuppression
Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors
Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression
Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy
Evolution of progressive multifocal leukoencephalopathy in HIV-infected patients
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
Smoldering myeloma presenting as progressive multifocal leukoencephalopathy: a case report